Cargando…

The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective

Detalles Bibliográficos
Autores principales:	Suh, Cheolwon, Park, Byeong-Bae, Kim, Won Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383584/ https://www.ncbi.nlm.nih.gov/pubmed/28401092 http://dx.doi.org/10.5045/br.2017.52.1.3

Ejemplares similares

Organ-specific considerations for marginal zone lymphomas in Korea, based on Consortium for Improving Survival of Lymphoma (CISL) and Korean clinical studies
por: Oh, Sung Yong, et al.
Publicado: (2019)

Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study
por: Lee, Seul, et al.
Publicado: (2015)

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)
por: Kim, Seok Jin, et al.
Publicado: (2011)

Review of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working Party
por: Suh, Cheolwon, et al.
Publicado: (2013)

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
por: Yhim, Ho-Young, et al.
Publicado: (2010)

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
por: Kim, Yu Ri, et al.
Publicado: (2012)

Consortium for Improving Survival of Lymphoma (CISL): a model of multicenter collaboration for lymphoma studies in Korea
por: Kim, Seok Jin
Publicado: (2015)

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
por: Oh, Sung Yong, et al.
Publicado: (2019)

Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study
por: Kim, Yu Ri, et al.
Publicado: (2023)

Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09)
por: Yoon, Dok Hyun, et al.
Publicado: (2017)

Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404)
por: Cho, Hyungwoo, et al.
Publicado: (2023)

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)
por: Yoon, Dok Hyun, et al.
Publicado: (2016)

Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma
por: Kang, Byung Woog, et al.
Publicado: (2014)

Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL)
por: Kim, Kyoung Ha, et al.
Publicado: (2023)

Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update
por: Hong, Jung Yong, et al.
Publicado: (2016)

Unlocking secrets of microbial ecotoxicology: recent achievements and future challenges
por: Hellal, Jennifer, et al.
Publicado: (2023)

Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022)

Volcanic electrification: recent advances and future perspectives
por: Cimarelli, Corrado, et al.
Publicado: (2022)

Integrative approaches in cryogenic electron microscopy: Recent advances in structural biology and future perspectives
por: Banerjee, Aneek, et al.
Publicado: (2021)

Applications and future of aptamers that achieve rapid-onset anticoagulation
por: Yu, Haixiang, et al.
Publicado: (2023)

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
por: Seo, Jeongkuk, et al.
Publicado: (2017)

Plerixafor use for peripheral blood stem cell mobilization in Korea
por: Kim, Seok Jin, et al.
Publicado: (2013)

A perspective on recent findings and future strategies for reactive aldehyde removal in spinal cord injury
por: Herr, Seth A., et al.
Publicado: (2023)

Cryo-EM for battery materials and interfaces: Workflow, achievements, and perspectives
por: Weng, Suting, et al.
Publicado: (2021)

Recent Changes at Environmental Health Perspectives
por: Tilson, Hugh A.
Publicado: (2008)

Body Cavity–Based Lymphoma in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of Lymphoma
por: Shin, Junghoon, et al.
Publicado: (2019)

Surviving in the era of "Big Data"
por: Kwon, Seog-Woon
Publicado: (2013)

Exome Sequencing: Current and Future Perspectives
por: Warr, Amanda, et al.
Publicado: (2015)

Future of spine research: “The Asian perspectives”
por: Sakai, Daisuke, et al.
Publicado: (2018)

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends
por: Zhang, Haolin, et al.
Publicado: (2021)

Dog10K: the International Consortium of Canine Genome Sequencing
por: Wang, Guo-Dong, et al.
Publicado: (2019)

The Current and Future State of Department of Defense (DoD) Microbiome Research: a Summary of the Inaugural DoD Tri-Service Microbiome Consortium Informational Meeting
por: Glaven, Sarah, et al.
Publicado: (2018)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives
por: Weenink, Bas, et al.
Publicado: (2020)

Future Perspectives on the TNM Staging for Lung Cancer
por: Rami-Porta, Ramón
Publicado: (2021)

Marine Puupehenone and Puupehedione: Synthesis and Future Perspectives
por: Rosales Martínez, Antonio, et al.
Publicado: (2023)

Centre for Statistical and Methodological Excellence (CESAME): A Consortium Initiative for Improving Methodology in Randomised Clinical Trials
por: Jørgensen, Caroline Kamp, et al.
Publicado: (2023)

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium
por: Grossman, RL, et al.
Publicado: (2017)

Perspective and analysis of ammonia-based distributed energy system (DES) for achieving low carbon community in China
por: Du, Hui, et al.
Publicado: (2022)

CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma
por: Koh, Young Wha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g71mqiasvj5ftvlem20dfp9476